FDA Budget Faces $319 Million Cut Under Sequestration
This article was originally published in The Tan Sheet
Executive Summary
The estimated reduction, included in the White House OMB’s report to Congress, is equal to the cost of 900 to 1,200 agency employees, an agency advocate says. The across-the-board cuts loom with the failure of the congressional Super Committee to find $1.2 trillion in cuts over 10 years.
You may also be interested in...
Sequestration Could Drive An FDA Resources Review
FDA and advocates wait to see how an estimated 7.8% budget cut would be implemented, if enacted. Former agency officials say sequestration could lead to hiring freezes and program delays.
Worries About 180-Day Exclusivity Reforms Persist As User Fee Bill Advances
FDA-crafted legislative text emerges that generic industry says could weaken the incentive, but so far no changes are in the draft House and Senate bills.
Surprise US FDA Facility Inspections Resume In India
Unannounced facility visits also were to start again in China, but FDA Commissioner Robert Califf said they have been delayed by the COVID-19 outbreak in the country.